CD Bioparticles announces its custom synthesis services of Bio-Targeted Small Molecules Conjugated Magnetic Nanoparticles (MNPs).
CD Bioparticles launches a comprehensive range of exosome modification products and services to support researchers.
CD Bioparticles announces custom nucleic acid delivery particle synthesis services for gene therapy, gene editing, vaccines and immunotherapy.
Key Players in Focus and strategic insights
Lactocore Group, a rising biotech company, announced the acceptance of its subsidiary, Lactabico into BioLabs Heidelberg, the German hub of an international network of shared lab and office facilities for life science start-ups. This international community is known for its cooperative initiatives with major pharmaceutical companies, positioning Lactabico at the forefront of key industry collaborations…. Read more »
